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Sodium (Na+) can accumulate in the skin tissue, sequestered by negatively charged 
glycosaminoglycans (GAGs). During dietary salt overload, the amount and charge density 
of dermal GAG molecules – e.g., hyaluronic acid (HA) and chondroitin sulfate (CS) – 
increases; however, the regulation of the process is unknown. Previously, it has been 
demonstrated that the level of cyclooxygenase-2 (COX-2) activity and the content of 
prostaglandin E2 (PGE2) are elevated in the skin due to high-salt consumption. A link 
between the COX-2/PGE2 system and GAG synthesis was also suggested. 
We hypothesized that in dermal fibroblasts (DFs) high-sodium concentration activates the 
COX-2/PGE2 pathway and also that PGE2 increases the production of HA. Our further 
aim was to demonstrate that the elevation of the GAG content is ceased by COX-2 
inhibition in a salt overloaded animal model. For this, we investigated the messenger RNA 
(mRNA) expression of COX-2 and HA synthase 2 enzymes as well as the PGE2 and HA 
production of DFs by real-time reverse transcription PCR (qRT-PCR) and ELISA, 
respectively. The results showed that both high-sodium concentration and PGE2 treatment 
increases HA content of the media. Sodium excess activates the COX-2/PGE2 pathway 
in DFs, and COX-2 inhibition decreases the synthesis of HA. In the animal experiment, 
the HA- and CS disaccharide content in the skin of male Wistar rats was measured using 
high performance liquid chromatography-mass spectrometry (HPLC-MS). In the skin of 
rats receiving high-salt diet, the content of both HA‐ and monosulfated-CS disaccharides 
increased, whereas COX-2 inhibition blocked this overproduction. In conclusion, high-salt 
environment could induce GAG production of DFs in a COX-2/PGE2-dependent manner. 
Moreover, the COX-2 inhibition resulted in a decreased skin GAG content of the salt 
overloaded rats. These data revealed a new DF-mediated regulation of GAG synthesis in 
the skin during salt overload.
Keywords: sodium storage, hypertonicity, dermal fibroblast, skin, cyclooxygenase-2, prostaglandin E2, 
glycosaminoglycan, hypertension
Agócs et al. COX-2 Enhances Skin GAG Content
Frontiers in Physiology | www.frontiersin.org 2 October 2020 | Volume 11 | Article 561722
INTRODUCTION
While the detrimental effect of sodium (Na+) on hypertension 
is still being discussed heatedly, a new concept of regulated 
Na+ storage in the skin has emerged. Animal experiments 
verified the role of skin as a Na+ depository, which was 
confirmed by high resolution 23Na-MRI imaging in humans 
(Ivanova et  al., 1978; Titze et  al., 2003; Kopp et  al., 2012; 
Linz et  al., 2015). According to certain research data, Na+ 
concentration in the skin following salt consumption may 
exceed the level of 140  mmol/L (Wiig et  al., 2013). In 
the model proposed by Machnik et  al. (2009), the 
glycosaminoglycan (GAG)-bound Na+ ions generate local 
hypertonicity. This hypertonicity is sensed by the large 
number of macrophages simultaneously infiltrating the skin 
interstitium. Utilizing the cyclooxygenase (COX)-2-VEGF-C 
signaling pathway macrophages facilitate lymph capillary 
formation ultimately resulting in the clearance of the 
excess Na+ which has previously been deposited in the 
interstitium (Machnik et  al., 2009; Müller et  al., 2013;  
Zhang et  al., 2015).
A large fraction of GAG molecules is found in the skin. 
GAGs are high molecular weight, long-chained, polyanionic, 
polysaccharide molecules in the extracellular matrix (ECM), 
and on the surface of cells. GAGs can either be  unsulfated 
[hyaluronic acid (HA)], or sulfated [chondroitin sulfate (CS), 
dermatan sulfate, heparan sulfate, and keratan sulfate] in 
distinct positions. Due to their high charge density, they 
are capable of binding positively charged ions, including 
Na+, an ion present abundantly in the extracellular space 
(Farber et  al., 1957).
The amount of skin Na+-binding GAGs positively correlates 
with skin Na+ content (Fischereder et  al., 2017; Sugar et  al., 
2018). High salt consumption increases Na+ content as well 
as the amount of GAGs of the skin (Titze et  al., 2003, 2004), 
while in salt depletion, both of them decrease (Schafflhuber 
et  al., 2007; Sugar et  al., 2018; Lopes-Menezes et  al., 2019). 
Consensus holds that the Na+  storage mediated by GAGs 
is an actively regulated process. GAGs respond to altered 
Na+ concentration of the interstitium by changing their amount, 
and their charge density. Serving as a buffer against Na+ 
overload, Na+ storage on GAGs may blunt blood pressure 
(BP) rise (Titze et  al., 2002; Olde Engberink et  al., 2019). 
This phenomenon implies a strict quantitative and qualitative 
regulation of skin GAGs; however, the underlying mechanisms 
to date are not known in detail.
Prostaglandins are paracrine/autocrine regulators, with an 
important role in the regulation of Na+ balance and BP. COX 
enzymes are the rate-limiting factors in the synthesis of 
prostaglandin mediators. In the case of salt overload, both the 
expression of the inducible COX-2 isoform and the amount of 
prostaglandin E2 (PGE2) rise in the kidney medulla 
(Yang et al., 1998; Ye et al., 2006; Chen et al., 2008). PGE2 in 
turn hampers Na+ reabsorption in the thick ascending limb 
of loop of Henle and in the collecting duct – resulting in 
increased Na+ – and water excretion (Ando and Asano, 1995; 
Hebert et  al., 1995; Guan et  al., 1998).
COX-2 inhibitors slow down the formation of skin lymph 
capillaries and cause Na+ retention in the kidney (Harirforoosh 
and Jamali, 2005; Zhang et  al., 2015; Yang and Liu, 2017). 
These consequences (impaired lymph capillary density in the 
skin and renal Na+ retention) lead to salt-sensitive hypertension 
(Ye et  al., 2006; Zhang et  al., 2015), a well-known side effect 
of COX-2 inhibitors (Johnson et al., 1994; Muscara et al., 2000; 
Hocherl et  al., 2002).
Dermal COX-2/PGE2 system is affected by the consumption 
of a high-sodium diet, too. In a salt overload condition, 
expression of COX-2 is induced in macrophages resulting in 
enhanced levels of PGE2  in the skin (Zhang et  al., 2015). 
Keratinocytes have been identified in this process; also, they 
exhibited both elevated COX-2 activity and PGE2 production 
when exposed to a high Na+ environment (Xu et  al., 2015; 
Zhang et  al., 2015). However, other cells i.e., fibroblasts may 
also be  involved since they express COX-2 enzyme, too 
(Shiraishi et  al., 2008; Schirmer et  al., 2010; Li et  al., 2015; 
Saalbach et  al., 2015).
Experimental data imply that PGE2 strongly induces HA 
synthesis via the cAMP-dependent signaling pathway in 
fibroblasts and pericardial mesothelial cells by increased HAS1 
and HAS2 expressions (Yaron et  al., 1978; Honda et  al., 
1993). PGE2 is also a potent activator of dermal fibroblasts 
(DFs) during wound healing (Xu et  al., 2015). In several 
other tissue types, evidence has been found suggesting the 
interconnectivity of the COX-2 system and the GAG 
metabolism (Schmitz et  al., 2003; Rugheimer et  al., 2008).
Therefore, we hypothesized that the COX-2/PGE2 pathway 
may be  the most likely element in the regulation and/or 
synthesis of skin GAGs after salt overload. Our primary goal 
was to examine the effect of a high Na+ environment on 
COX-2 activity and HA synthesis in cultured primary human 
dermal fibroblasts, i.e., – the cell type responsible for the 
production of the bulk of ECM components. We  also studied 
the conceivable interconnectivity between the two regulatory 
systems. Our further aim was to examine the effect of the 
COX-2 inhibitor on the Na+, CS, and HA content in the 
skin of salt overloaded rats.
MATERIALS AND METHODS
Ethical Approval
All animal procedures were approved by the Committee of 
the Care and Use of Laboratory Animals in the Council 
of Animal Care at Semmelweis University, Budapest, 
Hungary (PEI/001/1731-9/2015). Isolation and culture on 
human dermal fibroblasts was approved by the local Ethics 
Committee of the University of Szeged, Hungary (CSR/039/ 
00346-5/2015).
Abbreviations: BP, Blood pressure; COX, Cyclooxygenase; CS, Chondroitin sulfate; 
DF, Dermal fibroblast; EP, Prostaglandin E2 receptor; GAG, Glycosaminoglycan; 
HA, Hyaluronic acid; HAS, Hyaluronic acid synthase; HSD, High-salt diet; LSD, 
Low-salt diet; Na+, Sodium; PGE2, Prostaglandin E2.
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Confirmation of Compliance
The investigators understand the ethical principles under which 
the journal operates and their work complies with this animal 
ethics checklist.
Animals
Healthy, 8-week-old, drug‐ and test-naive, male Wistar rats 
(RRID:RGD 13508588; Toxi-Coop Toxicological Research Centre, 
Dunakeszi, Hungary) were housed in an accredited, non-SPF 
animal care facility in a temperature-controlled room 
(22  ±  1.0°C) with constant light/dark cycles (12/12  h). The 
initial weight of the animals was 288  ±  9  g.
Experimental Design and Groups
Two types of dietary regimes were applied: low-salt diet (LSD) 
consisting of extremely low-salt rat chow (<0.1% NaCl, a 
virtually salt-deficient diet; Ssniff Gmbh, Soest, Germany) and 
tap water and high-salt diet (HSD) consisting of Na+ rich rat 
chow (8.0% NaCl; Ssniff Gmbh) and isotonic saline as drinking 
water. Rats had ad libitum access to food and drink. According 
to our breeding program, the food was exchanged every 2 days. 
Rats were treated daily with isotonic saline as a vehicle (V) 
or with celecoxib [C; 20  mg (kg body wt)−1  day−1; Celebrex, 
Pfizer, NY, United  States] administered by oral gavage. Two 
hundred micrograms celecoxib was dissolved in 5  ml saline, 
and the appropriate volume of the solution was administered 
according to body weight.
Following 1 week of acclimatization, the rats were randomized 
into three groups (n  =  8/group): (i) LSD  +  V; (ii) HSD  +  V; 
and (iii) HSD  +  C and were treated for 2  weeks. The 
experimental unit was a cage of animals (two rats/cage). The 
number of independent replications of this experiment was 
1 (n  =  1). The sample was calculated by power analysis. Type I 
error (α) and the power of study values were 0.05 and 0.8, 
respectively.
Arterial Blood Pressure
Systolic and diastolic BP were measured non-invasively on the 
tail vein of conscious animals using a CODA tail cuff standard 
monitoring system (Kent Scientific Corporation, Torrington, 
United States) once every week. Measurements were performed 
at the same time of the day, from morning to noon. This 
device uses a clinically validated, proprietary volume pressure 
recording technology (Kurtz et al., 2005). Several measurements 
during the acclimatization period allowed the animals to get 
used to the stress exerted by the measurement.
Tissue Harvest
At the end of the experiment, the animals were anesthetized 
by using an intraperitoneal ketamine-xylazine injection: 75  mg 
(kg body wt)−1 ketamine (Richter Gedeon, Budapest, Hungary) 
and 10 mg (kg body wt)−1 xylazine (Medicus Partner, Biatorbagy, 
Hungary). Blood samples were taken from the abdominal aorta 
at the end of the experiment. Urine samples were obtained 
by bladder puncture. The carcasses were skinned, and the skin 
samples were stored at −80°C until further investigation.
Determination of Serum and Urine 
Electrolytes
Na+ and creatinine concentration of blood and urine samples 
were analyzed with a Beckman Coulter AU480 Chemistry 
System (Beckman Coulter, CA, United  States).
Determination of Skin Na+ Content
Skin samples were desiccated at 90°C for 72  h, and then were 
frozen in liquid nitrogen and pulverized mechanically. Thereafter, 
1  g of the desiccated skin samples was dissolved in 5  ml HNO3 
overnight followed by adding 3  ml H2O2 (30%) to it. Samples 
were digested using microwave heated teflon bombs. Homogenized 
samples were diluted to a final volume of 25  ml and filtered 
through a 0.45  μm pore size syringe filter. Na+ concentration 
in the solutions was measured with a PFP7 type flame photometer 
(Buck Scientific, Norwalk, United  States). In order to eliminate 
eventual disturbances which ionization may cause, separate series 
of dilution were made to calibrate Na+ content. Every time, the 
standard of the other alkali metal was added to the standard 
series of dilution in a concentration as the sample to be measured 
required (Dipietro et  al., 1988; Chen et  al., 2005).
CS Extraction From Skin and 
Chondroitinase ABC Digestion
Fifty milliliter lysis buffer consisting of 4% SDS in 100  mM 
Tris pH 8.0 was added to dry skin tissue. Samples were 
thoroughly vortexed, and lysis was performed by heating the 
samples at 97°C for 30 min. The samples were then centrifuged 
at 16,000  g for 10  min, and 2  μl media was taken out from 
each sample for protein concentration determination. The 
media samples corresponding to 200  μg protein content were 
pipetted-off and were transferred to clean Eppendorf tubes, 
and 9× volume ice cold ethanol was added to precipitate the 
proteins overnight at −20°C. Next day, the samples were 
centrifuged at 4°C, 14,000  g for 20  min, and the pellets were 
washed twice by ice cold ethanol to remove the detergent. 
Then, the pellets were air dried and re-dissolved in 8  M 
urea, 50 mM ammonium bicarbonate and 5 mM DTT solution 
at a concentration of 5  μg/μl and incubated at 37°C for 
30  min. Samples were alkylated in the presence of 10  mM 
iodoacetamide at room temperature in the dark for 30  min. 
The samples were then diluted 10-fold by 50 mM ammonium 
bicarbonate and trypsin (Promega, Madison, WI, United States) 
was added at a ratio of 1:50 ratio and incubated at 37°C 
overnight. Next day, 0.5  μl formic acid was added to quench 
digestion, and the samples were applied on 10 kDa centrifugal 
membranes and centrifuged at 14,000  g for 15  min. The 
samples were washed twice with 50  μl 50  mM ammonium 
bicarbonate and centrifuged at 14,000  g for 8  min each time. 
The GAG chains were retained on the membrane and digested 
with chondroitinase ABC (Sigma, St. Louis, MO, United States) 
enzyme solution for 6  h at 37°C. The enzyme solutions 
consisted of 36.5  μl water, 45  μl 100  mM Tris pH 8.0 buffer, 
4.5  μl 100  mM ammonium acetate, and 4  μl 5  mU/μl 
chondroitinase ABC. Following the 6-h incubation process, 
50  μl 100  mM ammonium bicarbonate was added to each 
Agócs et al. COX-2 Enhances Skin GAG Content
Frontiers in Physiology | www.frontiersin.org 4 October 2020 | Volume 11 | Article 561722
sample, and the digestion products were centrifuged at 14,000 g 
for 10 min. The samples were washed twice with 50 μl 50 mM 




Prior to the HPLC-MS analysis, CS digests were cleaned using 
TopTip C18-graphite spintips. The SPE spintip was conditioned 
with 200 μl 80% ACN 0.1% TFA, then washed with 300 μlwater. 
The samples were applied in 50  μl water and reapplied once. 
The salts were washed with 150  μl water, finally, the CS 
disaccharides were eluted with 150  μl 40% ACN 0.05% TFA. 
The eluate was dried down and dissolved in 15  μl 10  mM 
ammonium formate in 75:25  v/v ACN:water (pH 4.4) and 
1  μl portions were injected without trapping. For microscale 
HPLC-MS investigation, a recently published method was used, 
as follows (Salt gradient chromatographic separation of CS 
disaccharides, Journal of Chromatography A, under review). 
An in-house packed HILIC-WAX capillary column (250  μm 
i.d.) was mounted on a Waters® nanoAcquity UPLC system 
(Waters, Milford, MA, United States) coupled to a high-resolution 
Waters® QTOF Premier™ Mass Spectrometer (Waters, Milford, 
MA, United States) via a normal electrospray ionization source. 
The column temperature was adjusted to 45°C by using an 
AgileSleeve capillary heater with MonoSleeve column heater 
controller (Analytical Sales and Services Inc., Flanders, NJ, 
United  States). The flow rate was set to 8  μl/min, as described 
before (Toth et  al., 2019). Eluent A was 10  mM ammonium 
formate in 75:25 v/v ACN:water (pH 4.4); Eluent B was 65 mM 
ammonium formate in 75:25  v/v ACN:water (pH 4.4). The 
gradient program was the following: starting from 6% B, the 
eluent ratio changed in 0.5 min to 12% B, and then in 4.5 min 
to 60% B. As a washing step, the composition was elevated 
to 100% B and held for 4  min, and it was followed by a 
5-min-long equilibration at the starting condition.
The mass spectrometry parameters were optimized for the 
highest sensitivity avoiding undesirable fragmentation in the 
ion source (Toth et  al., 2019). The capillary voltage was set 
to 2.4  kV, sampling cone to 20  eV, extraction cone to 4  V, 
and the ion guide to 1.5. The source temperature was 80°C, 
the desolvation temperature was 100°C, the cone gas 
was 25  L/h, and the desolvation gas 300  L/h. The investigated 
compounds were measured as singly-charged anions [deprotonated 
molecules, (M-H)−]. Multiply charged ions or adduct forms 
complicating the analysis were not observed.
Peaks were integrated with the QuanLynx add-in of Waters 
MassLynx 4.1 software, and then manually validated.
Relative content of skin HA disaccharides was measured 
by HPLC-MS as previously described (Sugar et  al., 2018).
Isolation of Human Dermal Fibroblasts
Primary human dermal fibroblasts were isolated from a healthy 
individual undergoing plastic surgery as described earlier 
(Kemeny et  al., 2016). Fibroblasts used for experiments were 
from the same individual.
Cell Cultures and Treatment Groups
Primary, human, and dermal fibroblasts were cultured in Dulbecco’s 
Modified Eagle’s Medium (DMEM; Gibco, supplied by Thermo 
Fisher Scientific, Cat. No. 41965062, Carlsbad, CA, United States) 
supplemented with a 10% fetal bovine serum (FBS; Gibco, Cat. 
No. 10500064), 1% L-glutamine and 1% penicillin/streptomycin, 
incubated in a humidified incubator with 5% CO2 at 37°C. The 
cells were plated on six-well plates (5  ×  105 cells/well; Sarstedt, 
Nümbrecht, Germany) without FBS supplementation for 24  h 
to reach cell adherence. Then, the medium was changed, and 
the cells were subjected to normal (NS; 150  mmol/L) or high 
Na+ concentration (HS; 200  mmol/L; Sigma-Aldrich, Cat. No. 
S6191, Darmstadt, Germany) with or without additional treatment 
of 40 nM PGE2 (Santa Cruz Biotechnology, Cat. No. sc-201225, 
Dallas, TX, United  States) or 4  μM celecoxib (Santa Cruz 
Biotechnology, Cat. No. sc-217869). The control cells were treated 
with vehicle (0.1% DMSO) only.
Treatment groups (n  =  6 wells/group) were as follows: (i) 
NS; (ii) NS  +  PGE2; (iii) NS  +  celecoxib; (iv) HS; and (v) 
HS  +  celecoxib.
After 2 or 24  h, the media samples were collected for ELISA 
measurements. The remaining cells were trypsinized with 0.25% 
trypsin-EDTA (Gibco, Cat. No. T4049) and centrifuged, and pellets 
were collected for Real-time reverse transcription PCR (qRT-PCR) 
measurements. Results were obtained from single experiments 
using technical repeats. In the case of independent experiments, 
their number is indicated in the legend of the corresponding figure.
Cell Proliferation and Cytotoxicity Assays
The effect of the applied Na+ concentrations and/or drug doses 
on cell proliferation and cytotoxicity were measured with MTT 
and LDH assays, respectively.
The cell viability of cultured human dermal fibroblast cells 
was detected by MTT assay. Cells were seeded in a 96-well 
plate, each well containing 5 × 103 cells and treated with different 
NaCl concentrations (150, 175, 200, and 250  mM) for 24  h. 
MTT (5  mg/ml, Sigma-Aldrich, Shanghai, China) was added 
to each well, and the plate was incubated for another 4  h, then 
150 μl DMSO (Sigma-Aldrich) was added. The plate was slowly 
oscillated until all the crystal substance was dissolved. Optical 
density (OD) was measured using a SpectroStar Nano microplate 
reader (BMG Labtech, Ortenberg, Germany) at 490  nm.
For LDH cytotoxicity assay, cultured human dermal fibroblast 
cells were seeded into 96-well plates at a density of 4  ×  103 
cells/well (n = 6 well/treatment group) and treated with different 
NaCl concentrations (150, 175, 200, and 250 mmol/L) for 24 h. 
The LDH assay was performed as previously described 
(Korzeniewski and Callewaert, 1983). All reagents were purchased 
from Sigma-Aldrich. The absorbance was recorded at 570 and 
690 nm as background in a SpectroStar Nano microplate reader 
(BMG Labtech, Ortenberg, Germany).
Messenger RNA Isolation and cDNA 
Synthesis
Total RNA was isolated from skin samples or cell pellets using 
Total RNA Mini Kit (Geneaid Biotech, Cat. No. RT050, 
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New Taipei City, Taiwan). The quality and quantity of the 
isolated RNA was determined with a NanoDrop ND-1000 
spectrophotometer (Baylor College of Medicine, Houston, TX, 
United  States). Thereafter, 500  ng total RNA was reverse-
transcribed using Maxima First Strand cDNA Synthesis Kit 
for qRT-PCR (Thermo Fisher Scientific, Cat No. K1642) according 
to the manufacturer’s instructions.
Real-Time Reverse Transcription 
Polymerase Chain Reaction
The mRNA expression of each sample was measured in 
triplicate with 20  μl/well final volume: 1  μl cDNA sample, 
1  μl of 10  μM forward and reverse primers (IDT, Coralville, 
IA, United  States), 7  μl PCR-grade water (Sigma-Aldrich, 
Cat. No. 3315932001), 10 μl 2× SensiFAST™ SYBR® No-ROX 
mix (Bioline, Cat. No. BIO-98005, London, UK). A LightCycler 
480 thermocycler (Roche Diagnostics, Mannheim, Germany) 
was used to perform PCR. Cycle parameters included an 
initial denaturation step (95°C for 2  min), followed by a 
three-step cycling: denaturation (95°C for 5  s), annealing 
(55–62°C for 5  s), and extension (72°C for 5–8  s), for 40 
cycles. Exact annealing temperatures and extension times 
can be  found in Table  1 for each primer pair. The results 
were analyzed by LightCycler 480 software version 1.5.0 
(Roche, RRID:SCR_012155) using the ΔΔCt method. 
Data were normalized against mRNA expression of 18S 
ribosomal RNA (RN18S, rat tissue) or glyceraldehyde-3- 
phosphate dehydrogenase (GAPDH, human dermal fibroblast 
cells) as an internal control and were presented as the 
ratio of their control values. Primers were designed by 
Lasergene PrimerSelect software version 7.1.0 (DNAStar, 
RRID:SCR_016295) based on nucleotide sequences from the 
National Center for Biotechnology Information’s nucleotide 
database (Table  1).
Enzyme-Linked Immunosorbent Assay
The quantity of PGE2 and HA in the cell culture media was 
determined according to the manufacturer’s instructions by 
using both the High Sensitivity PGE2 ELISA Kit (Abcam, Cat. 
No. ab133055, Cambridge, UK) and the Hyaluronic Acid ELISA 
Kit (R&D Systems, Cat. No. HYAL0), respectively. Both the 
standards and samples were run in duplicates. Optical density 
(OD) was measured using a SpectroStar Nano microplate reader 
(BMG Labtech).
Statistical Analyses
Data were analyzed using GraphPad Prism 7.0 Software 
(GraphPad Software, La Jolla, CA). Kolmogorov-Smirnov 
normality test was performed to determine the type of distribution 
of the values. In the case of parametric values, an unpaired 
Student’s t-test (two groups) or an ordinary one-way ANOVA 
followed by a Tukey’s post-hoc test (three or more groups) 
was applied. To analyze non-parametric data, a Mann-Whitney 
U rank test (two groups) or a Kruskal-Wallis rank test followed 
by a Dunn’s multiple-comparisons test (three or more groups) 
was performed. Data are presented as means ± SD (parametric) 
or medians ± interquartile range (non-parametric). A two-tailed 
value of p  <  0.05 was considered to be  statistically significant.
RESULTS
Determination of Optimal Na+ 
Concentrations With in vitro Cell Viability 
Assays
Na+ concentration 50  mmol/L higher than that of the control 
group (150  mmol/L) left both cytotoxicity (LDH assay) and 
cell viability (MTT assay) unchanged (Figures 1A,B). In contrast, 
Na+ at a concentration of 250  mmol/L resulted in cell damage.
TABLE 1 | Primer sequences and parameters.





































Gene identification numbers – (NCBI ID), taken from the National Center for Biotechnology Information database – nucleotide sequences of forward (F) and reverse (R) primers, 
specific optimal annealing temperatures (Ta) and product lengths are shown.
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Examination of COX-2/PGE2 Pathway 
Activity in Salt Overloaded Human DFs
In the cultured human DF cells, the mRNA expression levels 
of both COX-1 and COX-2 increased due to higher Na+ 
concentration; however, the rise in COX-2 expression was 
higher [COX-1: NS (normal sodium, 150  mmol/L): 
0.9983  ±  0.1928 (arbitrary unit); HS (high sodium, 
200  mmol/L): 1.493  ±  0.2711; COX-2: NS: 1.0  ±  0.2496; 
HS: 2.268  ±  0.3372; Figure  2A]. However, control osmolytes 
(mannitol or urea) failed to exert a similar effect (control: 
1.030  ±  0.345, NaCl: 1.920  ±  0.305, mannitol: 1.240  ±  0.350, 
and urea: 1.410  ±  0.470; Figure  2B). In accordance with 
increased COX-2 mRNA expression, the concentration of 
PGE2  in the media increased, too (NS: 308  ±  31.16  pg/ml; 
HS: 570.9  ±  54.28  pg/ml; Figure  2C). The expression levels 
of the two receptors of PGE2 – PGE2 receptor (EP) 2 and 
4 – were also measured: in the salt overloaded cells, the 
expression of EP2 decreased, whereas no change was detected 
in the expression of EP4 (EP2: NS: 1.0  ±  0.2286 arbitrary 
unit; HS: 0.3633  ±  0.1076; EP4: NS: 1.0  ±  0.0860; HS: 
0.97  ±  0.2259; Supplementary Figure  1).
Changes in the Expression Levels of HA 
Synthases and in the Production of HA in 
Salt Overloaded Human DFs
From among the two isoforms of HAS, the mRNA expression 
of HAS2 exhibited change; it increased considerably following 
exposure to elevated levels of Na+ (HAS1: NS: 1.0  ±  0.1538 
arbitrary unit; HS: 1.0  ±  0.1114; HAS2: NS: 0.9983  ±  0.1854; 
HS: 3.597  ±  1.1; Figure  3A). The rise was not induced by 
osmotic changes since only NaCl was effective in enhancing 
HAS2 mRNA, while the control osmolytes (mannitol or urea) 
failed to exert a similar effect (control: 0.965  ±  0.085, NaCl: 
2.745 ± 0.428, mannitol: 0.995 ± 0.1725, and urea: 1.3 ± 0.057; 
Figure  3B). Measuring the amount of HA in the media, a 
significant elevation was found in the HS group (NS: 
286.2  ±  20.94  ng/ml, HS: 567  ±  37.12  ng/ml; Figure  3C).
Demonstration of the Relationship 
Between the COX-2 Pathway and HA 
Synthesis
PGE2 administration alone resulted in higher mRNA expression 
of HAS2 at 2 h (NS: 0.9983 ± 0.3514, NS + PGE2: 2.695 ± 0.4282, 
NS  +  Celecoxib: 0.75  ±  0.0918, HS: 1.49  ±  0.5443, 
HS  +  Celecoxib: 1.465  ±  0.3653; Figure  4A). After 24  h, the 
higher Na+ concentration achieved significantly higher mRNA 
expression (NS: 1.002  ±  0.1189, NS  +  PGE2: 0.9617  ±  0.1843, 
NS  +  Celecoxib: 0.5133  ±  0.08042, HS: 1.815  ±  0.1469, 
HS  +  Celecoxib: 0.7383  ±  0.1459; Figure  4B). The effect of 
celecoxib was significant after 24  h in the NS  +  celecoxib 
group, it decreased gene expression to a level lower than that 
of the NS group (Figure 4B). When administered in combination 
with a high Na+ level, it blocked the HAS2 increase that 
develops in the cells that were treated with Na+ alone (Figure 4B).
The amount of the end product HA in the media was 
increased after 24  h as a result of PGE2 and a higher Na+ 
concentration, too (NS: 286.2  ±  20.94  ng/ml, NS  +  PGE2: 
624.6  ±  92.75  ng/ml, NS  +  Celecoxib: 195.1  ±  53.31  ng/ml, 
HS: 567  ±  37.12  ng/ml, HS  +  Celecoxib: 274  ±  6.54  ng/ml; 
Figure 4C). The effect of the latter was blocked with celecoxib.
The Combined Effect of Salt Overload and 
Celecoxib Administration on Na+ 
Concentration of Serum and on Urinary 
Na+ Excretion
The level of serum Na+ was slightly higher in group HSD  +  V, 
although in all three groups it remained within the physiological 
range [LSD  +  V (low-salt diet  +  vehicle): 139.0  ±  3.0  mmol/L, 
HSD  +  V (high-salt diet  +  vehicle): 141.5  ±  4.0  mmol/L, 
HSD  +  C (high-salt diet  +  celecoxib): 140.0  ±  1.0  mmol/L; 
Supplementary Figure  3]. Urinary Na+ excretion – expressed 
as the ratio of urinary Na+ and creatinine concentration – in 
group HSD  +  V was higher than in group LSD  +  V, as it 
was predictable from the elevated dietary Na+ intake (LSD + V: 
22.3 ± 10.4, HSD + V: 389.7 ± 176.2; Supplementary Figure 4). 
A B
FIGURE 1 | Determination of optimal sodium (Na+) concentrations with in vitro cell viability assays: (A) LDH cytotoxicity assay, and (B) MTT cell viability assay 
performed on cultured human dermal fibroblast cells after 24 h. Na+ concentration in the control media was 150 mM. n = 6 wells/group. One-way ANOVA test was 
performed. Data are presented as mean ± SD. Authors state that the number of independent experiments in reference to cell viability (MTT assay) was 3, and that 
the one shown is 1 representative of the corresponding repeats.
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A B C
FIGURE 2 | The examination of cyclooxygenase-2 (COX-2)/prostaglandin E2 (PGE2) pathway activity in salt overloaded human dermal fibroblasts after 24 h:  
(A) messenger RNA (mRNA) expression levels of the enzymes COX-1 and COX-2. (B) mRNA expression levels of the enzyme COX-2 in the media of cultured 
human dermal fibroblasts exposed to normal (150 mM NaCl = 300 mOsm/L) and high salt (200 mM NaCl = 400 mOsm/L) environment and the osmolytes mannitol 
(150 mM NaCl + 100 mM mannitol = 400 mOsm/L) and urea (150 mM NaCl + 100 mM urea = 400 mOsm/L). (C) PGE2 levels in the media of cultured human 
dermal fibroblasts. n = 5–6 wells/group. mRNA expression was normalized to GAPDH. NS, normal Na+ concentration and HS, high Na+ concentration. Unpaired 
t-test (A,C) and Kruskal-Wallis test (B) were performed. Data are presented as mean ± SD (A,C) or median ± interquartile range (B). Authors state that the number 
of independent experiments in reference to COX-2 mRNA expression, as well as PGE2 concentration was 3 and 2 respectively, and that the one shown is 1 
representative of the corresponding repeats.
A B C
FIGURE 3 | Changes in the expression levels of HA synthases (HAS) and in the production of HA in salt overloaded DFs after 24 h: (A) mRNA expression levels of 
the enzymes HAS1 and HAS2 in cultured human dermal fibroblasts in normal and high salt environment. (B) mRNA expression levels of the enzyme HAS2 in the 
media of cultured human dermal fibroblasts exposed to normal (150 mM NaCl = 300 mOsm/L) and high salt (200 mM NaCl = 400 mOsm/L) environment and the 
osmolytes mannitol (150 mM NaCl + 100 mM mannitol = 400 mOsm/L) and urea (150 mM NaCl + 100 mM urea = 400 mOsm/L). (C) Hyaluronic acid concentration 
measured in the media of cultured human dermal fibroblasts exposed to normal or high salt conditions. n = 6 wells/group. mRNA expression was normalized to 
GAPDH. NS, normal Na+ concentration and HS, high Na+ concentration. Unpaired t-test (A,C) and Kruskal-Wallis test (B) were performed. Data are presented as 
mean ± SD (A,C) or median ± interquartile range (B). Authors state that the number of independent experiments in reference to HAS2 mRNA expression was 3, and 
that the one shown is 1 representative of the corresponding repeats.
A B C
FIGURE 4 | Interconnectivity between the COX-2 pathway and HA synthesis: The effect of five different treatment regimes on (A) the relative mRNA expression of 
the enzyme HAS2 measured at 2 h, (B) the relative mRNA expression of the enzyme HAS2 measured at 24 h, (C) the hyaluronic acid concentrations measured in 
the media of cultured human dermal fibroblasts. n = 6 wells/group. mRNA expression was normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH). 
NS, normal Na+ concentration and HS, high Na+ concentration. One-way ANOVA tests were performed. Data are presented as mean ± SD. Authors state that 
results were obtained from single experiments using technical repeats.
Agócs et al. COX-2 Enhances Skin GAG Content
Frontiers in Physiology | www.frontiersin.org 8 October 2020 | Volume 11 | Article 561722
In group HSD  +  C, no significant decrease in urinary Na+ 
excretion was found (HSD  +  C: 232.4  ±  142.4).
The Combined Effect of Salt Overload and 
Celecoxib Administration on BP
Salt overload alone did not increase the systolic BP (LSD  +  V: 
117.7  ±  11.9  mmHg, HSD  +  V: 127.4  ±  10.4  mmHg; 
Supplementary Figure  5). However, when combined with the 
administration of celecoxib, the systolic BP rose significantly 
(HSD  +  C: 137.4  ±  8.6  mmHg).
The Combined Effect of Salt Overload and 
Celecoxib Administration on the mRNA 
Expression of COX-2 as Well as on the 
Content of Na+, CS‐ and HA-Disaccharides 
in the Skin
Following salt overload, the COX-2 mRNA expression increased 
in the skin [LSD  +  V: 1.0  ±  0.2543 (arbitrary unit), HSD  +  V: 
1.926 ± 0.7635; Figure 5A]. Additional administration of celecoxib 
prevented this elevation (HSD + C: 1.094 ± 0.5576; Figure 5A). 
The Na+ content of the skin in salt overloaded groups increased 
compared to the one in the LSD  +  V group; however, no 
difference between the Na+ content of HSD  +  V and HSD  +  C 
groups was measured (LSD  +  V: 0.168  ±  0.017  mmol/g dry 
skin, HSD  +  V: 0.268  ±  0.021  mmol/g dry skin, HSD  +  C: 
0.285  ±  0.054  mmol/g dry skin; Figure  5B). Furthermore, the 
content of CS in the skin was affected by the applied treatments, 
as well: the amount of both non-sulfated and monosulfated CS 
disaccharides significantly increased in the HSD  +  V group 
compared to the one in the LSD  +  V group (non-sulfated CS: 
LSD + V: 10,292 ± 2,489  fmol, HSD + V: 23,861 ± 12,089  fmol; 
nonosulfated CS: LSD  +  V: 63,763  ±  13,021  fmol, HSD  +  V: 
94,835  ±  12,480  fmol; Figure  5C). Interestingly, inhibition of 
COX-2 blocked the overproduction of monosulfated CS 
disaccharides in the skin of salt overloaded rats (HSD  +  C: 
72,942  ±  11,422  fmol; Figure  5C). In the case of disulfated 
CS, no difference was observed among groups (Figure  5C). 
Finally, the relative HA disaccharide content was increased in 
the skin of HSD + V rats compared to that of LSD + V animals 
(LSD  +  V: 1.000  ±  0.043, HSD  +  V: 1.151  ±  0.122); however, 
no elevation was observed in the HSD  +  C group (HSD  +  C: 
1.040  ±  1.124; Figure  5D).
DISCUSSION
We demonstrated with our results for the first time that under 
salt overloaded condition GAG production in the skin is 
regulated by the local prostaglandin system. The elevated 
extracellular Na+ concentration activates the COX-2/PGE2 
pathway in human dermal fibroblasts, which results in increased 
HA production. The relationship between the two regulatory 
systems was demonstrated by using cell culture and animal 
model, as well.
Our results demonstrate that dermal fibroblasts retain their 





FIGURE 5 | Effect of salt overload and celecoxib administration on the 
content of Na+, chondroitin-sulfate, and hyaluronic acid disaccharides, as well 
(Continued)
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exceeding 200  mmol/L (Figures  1A,B). This is in line with 
in vitro salt overload experiments and consistent with experimental 
interstitial tissue Na+ concentrations (180–200 mmol/L) measured 
in vivo following dietary salt load (Müller et  al., 2013;  
Wiig et  al., 2013; Zhang et  al., 2015).
The in vitro measurements performed on dermal fibroblasts 
proved that not only macrophages and keratinocytes, but 
dermal fibroblasts are also involved in the regulation and 
storage of skin Na+ content (Xu et  al., 2015; Zhang et  al., 
2015). One possible pathway is the COX-2/PGE2 pathway, 
which is expressed in both dermal macrophages and 
keratinocytes and responds to various stimuli, i.e., higher 
skin Na+ concentration. We  demonstrated a Na+ induced 
activation of the COX/PGE2 pathway in DF cells. In cultured 
human DF cells, mRNA expression levels of both COX-1 
and COX-2 increased due to higher Na+ concentration 
(Figure  2A). This increase can be  observed even in the 
constitutively expressed COX-1 isoform; however, to a lesser 
extent than in COX-2. Since control osmolytes did not exert 
similar effect, our data proved the specific, osmolarity 
independent effect of NaCl on COX-2 mRNA expression 
(Figure 2B). In accordance with the increased COX-2 mRNA 
expression, elevated concentration of PGE2  in the media was 
found (Figure  2C). Regarding the PGE2 receptors, the 
expression levels of the two receptors of PGE2 (EP2 and 
EP4) showed different response in salt overloaded cells; the 
mRNA expression of EP2 decreased, whereas no change was 
detected in the expression of EP4 (Supplementary Figure  1). 
A possible explanation for the downregulation of EP2 receptor 
is receptor desensitization, which is an indirect evidence of 
PGE2 rise. Interestingly, we  found instances in the literature 
which contradict the above pattern of EP receptor mRNA 
expression; PGE2 caused the downregulation of EP4 and the 
upregulation of EP2 receptor in macrophages and fibroblasts 
(Ikegami et  al., 2001; Shim, 2019). Therefore, the gene 
expressions of EP2 and EP4 are differentially regulated, the 
direction of change in gene expression probably depends on 
the trigger.
In a salt-loaded condition, the organism tries to bind and 
store the unnecessary Na+ mainly in the skin. GAG molecules 
due to their high charge density are capable of sequestering 
positively charged ions and molecules (Farber et  al., 1957). 
Therefore, extracellular GAGs are considered to play a crucial 
role in Na+ storage in salt loaded condition (Titze et al., 2004). 
There are two types of GAGs: the unsulfated HA and the 
sulfated GAGs. In the branched structure of GAGs, HA serves 
as a backbone for sulfated molecules. Since HA is an integrated 
part of all kinds of GAGs, our in vitro experiments focused 
on this macromolecule.
Specific enzymes, the HASs are responsible for the synthesis 
of HA; in mammals three, plasma membrane integrated isoforms 
are known. Among the isoforms, HAS1 and HAS2 synthetize 
longer chains of HA. In our cell culture experiments, only 
HAS2 was reactive to Na+ excess, and the increased HAS2 
mRNA expression facilitated the overproduction of HA 
(Figure  3A). Such reaction of fibroblasts seems to be  a 
compensatory and cell/tissue protecting cellular mechanism, 
which aims at neutralizing Na+. The use of osmotic controls 
(i.e., urea and mannitol) revealed that HAS2 expression is not 
solely a response to an increased external osmolality, but a 
specific result exerted by the NaCl solution independently of 
its osmotic properties (Figure  3B).
Since the Na+ load increased both HAS2 and COX-2 
expressions of DFs, we  investigated the possible relationship 
between these two systems. Administration of both PGE2 
or Na+ load had an impact on HAS2 enzyme expression, 
although they exerted their effect at different time points 
(Figures  4A,B). This implies differences in the kinetics of 
the two signal transduction pathways. The fact that PGE2 
was able to induce HA synthesis directly proves that PGE2 
is a potent activator of HA synthesis. Moreover, the blocked 
overexpression of HAS2 with the impaired overproduction 
of HA 24  h after COX-2 inhibition in the media with high 
Na+ concentration indicates the interconnectivity of COX-2/
PGE2 pathway and HA synthesis in a high Na+ environment 
(Figures  4B,C).
Data in the literature obtained from animal experiments 
proposed the involvement of COX-2/PGE2 pathway in the 
regulation of skin Na+ content. Higher Na+ concentration 
measured in the skin is likely to increase the COX-2 activity 
of macrophages and keratinocytes (Xu et al., 2015; Zhang et al., 
2015). Our cell culture experiments supported the fact that 
COX-2 activation occurred in dermal fibroblasts too. Nevertheless, 
certain products of the enzyme COX-2 increase the HA 
production of DFs. On the one hand, DFs act in an autocrine/
paracrine manner, in a way that one cell activates itself or its 
neighbors. On the other hand, COX-derivatives produced by 
nearby macrophages or keratinocytes may also trigger the DFs’ 
HA production.
In the animal experiment, our data confirm previous 
observations, where the overall expression of COX-2 mRNA 
increased in response to salt overload (Figure 5A; Zhang et al., 
2015). Elevated COX-2 mRNA expression is evidently an 
integrated effect of different cell types. When COX-2 was 
inhibited in the salt loaded animals (HSD + C) in our experiments, 
the COX-2 mRNA expression exhibited a similar level of the 
control group. This fact certainly proves the pharmacological 
blockade of the whole system, which is a phenomenon attributed 
to the cessation of COX-2’s positive feedback effect.
No biologically relevant change in the level of serum Na+ 
was detected; serum Na+ concentration remained in the 
FIGURE 5 |  as on the mRNA expression of COX-2 in the skin: (A) mRNA 
expression levels of the enzyme COX-2 in the skin of rats. Contents of  
(B) Na+, (C) chondroitin-sulfate, and (D) hyaluronic acid disaccharides of rat 
skin. The chondroitin-sulfate disaccharide content of the skin refers to 200 μg 
protein (non-sulfated, monosulfated, and disulfated disaccharides). n = 6–8 
rats/group. The mRNA expression was normalized to 18S RNA. LSD + V: 
low-salt diet + vehicle; HSD + V: high salt-diet + vehicle; HSD + C: high salt 
diet + celecoxib; CS, chondroitin-sulfate; HA, hyaluronic acid; and ns, not 
significant. Kruskal-Wallis test (A) and one-way ANOVA tests (B–D) were 
performed. Data are presented as median ± interquartile range (A) or 
mean ± SD (B–D). Authors state that results were obtained from a single 
experiment.
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physiological range even in the salt overloaded groups 
(Supplementary Figure 3). In contrast to serum Na+ content, 
skin Na+ levels exhibited significant change, which is in line 
with literature data (Titze et  al., 2003; Wiig et  al., 2013; 
Figure  5B). Surprisingly, no reduction in Na+ content was 
detected when high Na+ diet, and COX-2 inhibition was 
administered simultaneously. We  hypothesized that skin Na+ 
content reduces in line with GAG synthesis. After all, Na+ 
content was not reduced by COX-2 inhibition. The answer 
probably lies in the complex effect of COX-2 inhibition on 
Na+ homeostasis. COX-2 inhibition may have increased skin 
Na+ content by affecting two distinct processes: either by 
inhibiting lymph capillary proliferation of the skin and 
disturbing the clearance of tissue Na+, or by facilitating the 
expression of Na+ channels in the kidney and consequent 
Na+ reabsorption. Although we  did not find any significant 
decrease in urinary Na+ excretion in the case of COX-2 
inhibition (Supplementary Figure  4), it is a well-known 
effect in the literature (Harirforoosh and Jamali, 2005;  
Yang and Liu, 2017).
According to literature data, high salt consumption increases 
the amount of GAGs of the skin. Our findings corroborate 
this phenomenon; the amount of both CS‐ (non-sulfated and 
monosulfated) and HA-disaccharides increased in the skin 
of salt overloaded experimental animals (Figures  5C,D). 
Concomitant COX-2 inhibition blocked the overproduction of 
both GAGs (Figures 5C,D), suggesting that COX-2 is involved 
not only in the regulation of HA but also in sulfated GAGs. 
The results from skin HA measurement are in line with the 
data regarding HA content in cell cultures and CS content in 
the skin during salt overload. Therefore, these results support 
the proposed mechanism of the effect of COX-2 inhibition 
on the regulation of GAGs.
These findings are in contrast with the observation of 
Zhang et  al. (2015), who described the opposite effect; the 
Na+ content of the skin grew even further in salt overloaded 
animals. In their experiment, only the enzyme of skin-infiltrating 
macrophages had been knocked out, keratinocytes and DFs 
retained their COX-2 activity; therefore, presumably they also 
retained their ability to produce GAGs. In our experiment, 
COX-2 inhibition was achieved by Celecoxib administration: 
a treatment affecting enzyme activity in all cells of the body. 
Methodical differences between the two studies may give 
explanation to the contradictory results; in the article of Zhang 
et  al. (2015), COX-2 inhibition increased skin Na+ content, 
whereas in our experiment similar intervention left skin Na+ 
level unchanged. In our case, COX-2 activity of macrophages, 
keratinocytes, and fibroblasts in the skin decreased, which – in 
light of our results – could have repressed GAG production 
in the skin. Thus, Na+ accumulated in the body – resulting 
from either inhibition of lymph capillary proliferation or 
increased Na+ retention in the kidneys – was probably unable 
to bind to GAGs and increase Na+ content of the skin.
No change in BP was measured in the animals of group 
HSD  +  V – in line with the fact that the Wistar strain 
used is considered to be  a relatively salt resistant one 
(Supplementary Figure 5). In contrast, elevated BP developed 
in the group receiving the combination of high Na+ and 
celecoxib treatment (HSD + C). Three mechanisms may explain 
the hypertensive effect of the drug: (1) Na+ retention in 
FIGURE 6 | The mechanism by which the high-sodium environment promotes increased glycosaminoglycan (GAG) production in the skin. The elevated 
extracellular Na+ concentration activates the COX-2/PGE2 pathway in keratinocytes, macrophages, and dermal fibroblasts. The resulting PGE2 molecules exert their 
effect in both autocrine and paracrine manners on dermal fibroblasts, leading to increased synthesis of GAGs. These negatively charged macromolecules can bind 
more sodium ions in the interstitium.
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the kidney, (2) cessation of the vasodilatory effect resulting 
from decreased prostacyclin production of the blood vessel 
wall, and (3) reduced lymph vessel formation (Harirforoosh 
and Jamali, 2005; Yu et  al., 2010; Zhang et  al., 2015; Yang 
and Liu, 2017). Apart from these documented effects of 
COX-2 inhibition, the decreased production of GAGs 
(i.e., deteriorated Na+-binding capacity of the skin) may have 
also contributed to the increased BP.
However, the lack of a control group on a standard-salt 
diet is a possible limitation of our experiment. The experimental 
design used in our study (low-salt diet vs. high-salt diet) is 
a well-established model in the literature, despite exposing 
both groups to the extremes of sodium ingestion during the 
course of the experiment (Titze et  al., 2002, 2003, 2004; 
Machnik et  al., 2009; Jantsch et  al., 2015; Nikpey et  al., 2017; 
Benz et  al., 2018). In this model, instead of using a standard-
salt diet group, the high-salt diet induced changes are compared 
directly to the state of salt deprivation. In the literature, the 
use of these two dietary groups resulted in clear difference 
in skin sodium content, and certain pathophysiological 
alterations were associated with this difference. In our own 
experiments, too, we  attributed pathophysiological changes 
to differences in skin salt content. Moreover, these findings 
were strongly supported by our in vitro experiments, too. 
However, using an additional normal-salt diet group, in which 
the consumed amount of sodium would meet the animals’ 
needs, it would provide a more detailed picture of the 
relationship of salt overload and COX-2-mediated GAG 
production in the skin.
In summary, we demonstrated that high-sodium environment 
increases GAG synthesis of dermal fibroblasts via the activation 
of the COX-2/PGE2 pathway (Figure  6). Beside other cell 
types, dermal fibroblasts are also capable of producing PGE2. 
The resulting PGE2 molecules act on fibroblasts in both paracrine 
and autocrine manners. Moreover, the salt overloaded Wistar 
rats treated with the COX-2 inhibitor celecoxib failed to increase 
the amount of Na+-binding GAGs in the skin. Taken together, 
in case of salt overload, GAG production in the skin is regulated 
by the local prostaglandin system. These data provide further 
insight into the fibroblast-mediated regulation of GAGs in the 
skin during high salt consumption, as well as into the dermal 
Na+ homeostasis.
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